Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema.
Magnette
J-L
JL
Novartis Consumer Health SA, PO Box 269, 1260-1, Nyon, Switzerland. john.magnette@ch.novartis.com
Kienzler
J-L
JL
Sallin
D
D
Ménart
C
C
Nollevaux
F
F
Knops
A
A
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019540:Area Under Curve; D004008:Diclofenac / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D004890:Erythema / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy; D014466:Ultraviolet Rays
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004008:Diclofenac